The vaccine has demonstrated a high efficacy rate after one dose, but the company itself has not suggested any policy changes.
For your security, we need to re-authenticate you.
Click the link we sent to , or click here to log in.
Is Pfizer Recommending a Switch to a Single-…
The vaccine has demonstrated a high efficacy rate after one dose, but the company itself has not suggested any policy changes.
Create your profile
Only Dispatch Members only can comment on this post
Check your email
For your security, we need to re-authenticate you.
Click the link we sent to , or click here to log in.